Status:
UNKNOWN
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
Lead Sponsor:
Fujian Cancer Hospital
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18-65 years
Brief Summary
Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer. The last three decades of research in head and neck radiation oncology have largely focused on improvements in survival, which have mo...
Eligibility Criteria
Inclusion
- Received treatment with Reduced Volume Intensity Modulated Radiation Therapy
- Age 18 or above, upper limit 65
- Ability to comply with the protocol
Exclusion
- History of recurrent nasopharyngeal disease
- A history of any physical, psychological or social condition which would impair with the ability of the patient to cooperate in this study
- Unable to provide consent
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06136962
Start Date
December 1 2023
End Date
December 1 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of radiation oncology, Fujian cancer hospital
Fuzhou, Fujian, China, 350014